Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2017-11-01 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于取得两项医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (871 characters) from a company about obtaining two medical device registration certificates issued by a provincial food and drug regulatory authority. It includes details about the certificates, their validity, and intended use. There is no financial data, no mention of financial results, no management discussion, no voting results, no regulatory certifications, or other report types. The document is an official announcement of a regulatory approval related to product registration, not a financial report or meeting material. Given the content and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2017-11-01 Chinese
独立董事关于公司第三届董事会第十七次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on matters discussed at the company's 17th board meeting of the third session, dated October 27, 2017. It includes opinions on continuing to appoint the 2017 audit firm and providing guarantees to related parties. The content focuses on board-level decisions and independent directors' assessments rather than full financial statements or audit reports. It is not a full audit report (AR) or annual report (10-K), nor is it a regulatory filing or announcement. The document is clearly related to board/management information, specifically independent directors' opinions on board meeting matters, which fits the Board/Management Information (MANG) category.
2017-10-27 Chinese
关于召开2017年第四次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about convening the 2017 fourth extraordinary general meeting of shareholders for the company 三诺生物传感股份有限公司. It includes information about the meeting date, voting procedures (both in-person and online), agenda items to be discussed (such as appointment of the 2017 audit firm and bank credit application), registration details, and proxy forms. The document is a formal announcement inviting shareholders to attend and vote at the meeting, rather than the actual minutes, voting results, or financial reports. It does not contain financial statements or management discussion but focuses on the meeting logistics and agenda. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2017-10-27 Chinese
关于拟续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (信永中和会计师事务所) as the auditor for the company's 2017 financial statements. It details the board and supervisory committee's approval process, the auditor's qualifications, and the audit fee. The document does not contain the audit report itself or detailed financial statements, but rather the company's intention and approval to continue the auditor engagement. The document length is short (1562 characters) and it is an announcement about the audit appointment, not the audit report or financial statements. Therefore, it fits best under Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. However, since it is an announcement of auditor appointment and not the audit report, it is more appropriate to classify it as Regulatory Filings (RNS) because it does not contain the audit report or financial data, and is not a full audit report document. The document is not a report publication announcement (RPA) because it does not mention report release or availability. Hence, the best classification is Regulatory Filings (RNS).
2017-10-27 Chinese
关于申请银行综合授信及为关联方提供担保的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the company's application for a comprehensive bank credit facility and provision of guarantees for a related party. It includes extensive information about the guarantee arrangements, the related party's financial status, board and independent director opinions, and approval procedures. The content focuses on financing and guarantee activities rather than financial results, management changes, or legal proceedings. It is not a financial report, earnings release, or audit report. The document is a formal announcement about capital/financing updates related to guarantees and credit facilities. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a regulatory filing fallback.
2017-10-27 Chinese
2017年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "三诺生物传感股份有限公司 2017 年第三季度报告全文" which translates to "Sinocare Inc. 2017 Third Quarter Report Full Text." It contains detailed financial data including balance sheets, profit and loss statements, cash flow analysis, and notes on financial performance for the third quarter of 2017. The presence of comprehensive financial statements and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial data rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2017-10-27 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.